India  
 
NewsR.in

IPC raises alert regarding adverse reactions to meftal painkiller

IndiaTimes Thursday, 7 December 2023
The Indian Pharmacopoeia Commission (IPC) has issued a drug safety alert urging healthcare professionals and patients to monitor adverse reactions associated with the painkiller Meftal, commonly prescribed for menstrual cramps and rheumatoid arthritis. Meftal, containing mefenamic acid, is used for conditions like rheumatoid arthritis, osteoarthritis, dysmenorrhea, mild to moderate pain, inflammation, fever, and dental pain. The commission's alert highlighted adverse drug reactions from the Pharmacovigilance Programme of India (PvPI) database, revealing cases of eosinophilia and systemic symptoms (DRESS) syndrome.
0
shares		ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: Painkiller Meftal Spas Can Cause ‘Adverse Reaction’, Indian government issues alert | Oneindia

Painkiller Meftal Spas Can Cause ‘Adverse Reaction’, Indian government issues alert | Oneindia 02:19

 Next time you pop a Meftal, a commonly used non-steroidal anti-inflammatory drug (NSAID), to get rid of your pain, do so after consulting a doctor on dosage and clarifying whether you need it at all. The Indian Pharmacopoeia Commission (IPC) has issued a drug safety alert about the common painkiller,...

You Might Like


💡 newsR Knowledge: Other News Mentions


Related news from verified sources

IPC issues alert against adverse reactions of painkiller Meftal

 The mefenamic acid painkiller is prescribed in the treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhoea, mild to moderate pain, inflammation, fever...
DNA